Effects of angiotensin II blockade on the development of autoimmune thyroiditis in nonobese diabetic mice

Clinical Immunology

Volumn 126, Issue 1, 2008, Pages 97-103

  Mori, Kouki ^a   Yoshida, Katsumi ^b   Tani, Jun ichi ^a   Nakagawa, Yoshinori ^a   Hoshikawa, Saeko ^a   Ozaki, Hiroshi ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Autoimmunity; Hashimoto's thyroiditis; NOD mouse

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; CONCANAVALIN A; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IODIDE; LISINOPRIL; LOSARTAN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; VALSARTAN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HASHIMOTO DISEASE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; ENALAPRIL; HASHIMOTO DISEASE; LOSARTAN; MICE; MICE, INBRED NOD; SODIUM IODIDE; THYROGLOBULIN;

EID: 37249021475     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.08.018     Document Type: Article

References (35)

1. Suzuki Y., Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V., and Egido J. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35 (2003) 881-900
2. Ruiz-Ortega M., Lorenzo O., Rupérez M., König S., Wittig B., and Egido J. Angiotensin II activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ. Res. 86 (2000) 1266-1272
3. Marrero M., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., and Bernstein K.E. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375 (1995) 247-250
4. Nataraj C., Oliverio M.I., Mannon R.B., Mannon P.J., Audoly L.P., Amuchastegui C.A., Ruiz P., Smithies O., and Coffman T.M. Angiotensin II regulates cellular responses through a calcineurin-dependent pathway. J. Clin. Invest. 104 (1999) 1693-1701
5. Wolf G., Ziyadeh F.N., Thaiss F., Tomaszewski J., Caron R.J., Wenzel U., Zahner G., Helmchen U., and Stahl R.A.K. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J. Clin. Invest. 100 (1997) 1047-1058
6. Ruiz-Ortega M., Bustos C., Hernández-Presa M.A., Lorenzo O., Plaza J.J., and Egido J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J. Immunol. 161 (1998) 430-439
7. Shao J., Nangaku M., Miyata T., Inagi R., Yamada K., Kurokawa K., and Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42 (2003) 31-38
8. Lapteva N., Ide K., Nieda M., Ando Y., Hatta-Ohashi Y., Minami M., Dymshits G., Egawa K., Juji T., and Tokunaga K. Activation and suppression of renin-angiotensin system in human dendritic cells. Biochem. Biophys. Res. Commun. 296 (2002) 194-200
9. Nahmod K.A., Vermeulen M.E., Radien S., Salamone G., Gamberale R., Fernández-Calotti P., Alvarez A., Nahmod V., Giordano M., and Geffner J.R. Control of dendritic cell differentiation by angiotensin II. FASEB J. 17 (2003) 491-493
10. Constantinescu C.S., Goodman D.B.P., and Ventura E.S. Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol. Lett. 62 (1998) 25-31
11. Fukazawa M., Satoh J., Sagara M., Muto G., Muto Y., Nishimura S., Miyaguchi S., Qiang X.L., Sakata Y., Nakazawa T., Ikehata F., Ohta S., and Toyota T. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo. Immunopharmacology 36 (1997) 49-55
12. Sagawa K., Nagatani K., Komagata Y., and Yamamoto K. Angiotensin receptor blockers suppress antigen-specific T cell responses and ameliorate collagen-induced arthritis in mice. Arthritis Rheum. 52 (2005) 1920-1928
13. Dalbeth N., Edwards J., Fairchild S., Callan M., and Hall F.C. The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis. Rheumatology 44 (2005) 24-31
14. Godsel L.M., Leon J.S., Wang K., Fornek J.L., Molteni A., and Engman D.M. Captopril prevents experimental autoimmune myocarditis. J. Immunol. 171 (2003) 346-352
15. Champion B.R., Cooke A., and Rayner D.C. Thyroid autoimmunity. Curr. Opin. Immunol. 4 (1992) 770-778
16. Jansson R., Totterman T.H., Sallstrom J., and Dahlberg P.A. Thyroid-infiltrating T lymphocyte subsets in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 56 (1983) 1164-1168
17. Paschke R., Schuppert F., Taton M., and Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J. Endocrinol. 141 (1994) 309-315
18. Ajjan R.A., Watson R.F., and Weetman A.P. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin. Exp. Immunol. 105 (1996) 523-528
19. Damotte D., Colomb E., Cailleau C., Brousse N., Charreire J., and Carnaud C. Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis. Eur. J. Immunol. 27 (1997) 2854-2862
20. Tani J.-I., Mori K., Hoshikawa S., Nakazawa T., Satoh J., Nakagawa Y., Ito S., and Yoshida K. Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur. J. Endocrinol. 147 (2002) 809-814
21. Jin Z., Mori K., Fujimori K., Hoshikawa S., Tani J.-I., Satoh J., Ito S., Satomi S., and Yoshida K. Experimental autoimmune thyroiditis in non-obese diabetic mice lacking interferon regulatory factor-1. Clin. Immunol. 113 (2004) 187-192
22. Horiuchi M., Yamada T., Hayashida W., and Dzau V.J. Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J. Biol. Chem. 272 (1997) 11952-11958
23. Fukuyama K., Ichiki T., Takeda K., Tokunou T., Iino N., Masuda S., Ishibashi M., Egashira K., Shimokawa H., Hirano K., Kanaide H., and Takeshita A. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41 (2003) 598-603
24. Montiel M., and Jiménez E. Characterization of angiotensin II receptors (binding and mRNA) in the rat thyroid gland. J. Mol. Endocrinol. 20 (1998) 299-304
25. Chen K., Wei Y., Sharp G.C., and Braley-Mullen H. Inhibition of TGFβ1 by anti-TGFβ1 antibody and lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis. J. Immunol. 169 (2002) 6530-6538
26. Saboori A.M., Rose N.R., Butscher W.G., and Burek C.L. Modification of a nonincinerative method for determination of iodine in iodoproteins. Anal. Biochem. 214 (1993) 335-338
27. Kong Y., David C.S., Giraldo A.A., Elrehewy M., and Rose N.R. Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J. Immunol. 123 (1979) 15-18
28. Mazzali M., Kanellis J., Han L., Feng L., Xia Y.-Y., Chen Q., Kang D.-H., Gordon K.L., Watanabe S., Nakagawa T., Lan H.Y., and Johnson R.J. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am. J. Physiol. 282 (2002) F991-F997
29. Zhou Y., Chen R., Catanzaro S.E., Hu L., Dansky H.M., and Catanzaro D.F. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. Am. J. Hypertens. 18 (2005) 486-492
30. Peeters A.C.T.M., Netea M.G., Kullberg B.J., Thien T., and van der Meer J.W.M. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 94 (1998) 376-379
31. Wu L., Iwai M., Nakagami H., Li Z., Chen R., Suzuki J., Akishita M., de Gasparo M., and Horiuchi M. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104 (2001) 2716-2721
32. Kunori Y., Muroga Y., Iidaka M., Mitsuhashi H., Kamimura T., and Fukamizu A. Species differences in angiotensin II generation and degradation by mast cell chymases. J. Recept. Signal Transduct. Res. 25 (2005) 35-44
33. Constantinescu C.S., Ventura E., Hilliard B., and Rostami A. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotoxicol. 17 (1995) 471-491
34. de Albuquerque D.A., Saxena V., Adams D.E., Boivin G.P., Brunner H.I., Witte D.P., and Singh R.R. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int. 65 (2004) 846-859
35. Watanabe M., Yamamoto N., Maruoka H., Tamai H., Mitsuzuka F., Miyauchi A., and Iwatani Y. Independent involvement of CD8+CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid 12 (2002) 801-808